P040 Tivozanib pharmacokinetic (PK)/pharmacodynamic (PD) analysis of blood pressure (BP) and soluble vascular endothelial growth factor receptor 2 (sVEGFR2) in patients with advanced renal cell carcinoma (RCC)

✍ Scribed by Nosov, D.A.; Motzer, R.J.; Loewy, J.; Hodge, L.; Esteves, B.; Berkenblit, A.; Yin, W.; Dykstra, K.; Hutson, T.E.; Cotreau, M.M.

• Book ID: 122591803
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 260 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)60417-0